BioMarin Pharmaceutical (BMRN) - Net earnings per share (EPS TTM)

Symbol and logo of brand biomarin.com (BMRN)

BioMarin Pharmaceutical is a leader in the therapy of rare genetic pathologies, possessing exceptional pricing power over unique medications. This 12-month EPS chart demonstrates the operational resilience of the business, where the value of -0.10 characterizes this level. Despite risks stemming from the development of gene editing, BioMarin Pharmaceutical is restructuring its portfolio, focusing on the commercial scaling of its most successful orphan drugs.

BMRN (biomarin.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for BioMarin Pharma (BMRN)

- share price and expert price forecast:
Stock Quotes BioMarin Pharmaceutical|BMRN - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization BioMarin Pharmaceutical|BMRN - Total Enterprise Value
- business book valuation details:
Book Value per Share BioMarin|BMRN - Accounting Capitalization|Market Cap to Net Assets Ratio biomarin.com|BMRN - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity BioMarin Pharmaceutical|BMRN - Long-Term Liabilities to Equity|Short-Term Debt to Capital BioMarin Pharmaceutical|BMRN - Aggregate Debt Obligations|Debts to Book Capitalization BioMarin Pharmaceutical Inc.|BMRN - Company Long-Term Debts|Company Short-Term Debt BioMarin|Quick Liquidity biomarin.com
- net income and valuation multiples indicators:
BMRN - Net Income|Projected Future Earnings BioMarin Pharmaceutical|BMRN - P/E Multiple|Forward P/E Multiple BioMarin Pharma|BMRN - Price/Earnings to Growth Ratio|EV/EBITDA Multiple BioMarin|BMRN - Operating income before deduction of amortization|Earnings per share for the last twelve months BioMarin|BMRN - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months biomarin.com|BMRN - Net earnings per share growth this year|Earnings growth forecast for next year BioMarin Pharmaceutical
- sales volume and revenue information:
BMRN - Revenue and Sales Volume|Company Projected Revenue BioMarin|BMRN - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple BioMarin|BMRN - Annual Revenue Growth (Last Twelve Months)
General company analysis:biomarin.com (BMRN)
Mass-produced product of BioMarin Pharmaceutical Inc.

To minimize risks, investors should select assets with stable net profit dynamics, calculated as the ratio of total income to the number of shares over a rolling year. In the case of BioMarin Pharmaceutical (BMRN), this metric reflects the efficiency of monetizing joint genetic developments; therefore, sharp fluctuations in the per-share profit trend over the last 12 months may signal a revaluation of the business value.

Competitors of BioMarin Pharmaceutical (BMRN)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BBIO (BridgeBio) - Net earnings per share (EPS TTM)|BGM: Earnings per share for the trailing year|Net earnings per share for the last 12 months COGT (Cogent Biosciences, Inc.)|XERS (Xeris Biopharma Holdings, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)